Taperdex 6-day
Product Images NDC 42195-221

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Taperdex 6-day (NDC 42195-221). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xspire Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Struc-1 (Struct 6)

FDA Label Image

Tapernw6 (Taperd 6)

Tapernw6 (Taperd 6)
This is a medication package for TaperDex, an oral steroid therapy containing dexamethasone 1.5mg tablets. The package contains 21 tablets and instructions for a 6-day tapered dosage schedule. The medication should be taken with meals and at least three hours apart. The medication should not be discontinued without consulting a healthcare practitioner. TaperDex is not bioequivalent to any other 15mg dexamethasone tablets and has no generic substitute. Store the package at 20-25°C and keep out of reach of children.*
FDA Label Image

Taperdpr (Taprdex6 121)

Taperdpr (Taprdex6 121)
This is a medication description for TaperDex, specifically dexamethasone 15mg tablets. It provides information on the product's NDC (42195-121-06) and how it is used as a tapered oral steroid therapy. The tablets should be taken as per instructions, with the first six taken on the day the prescription is received. It's important to keep the medication out of reach of children and not discontinue it without consulting your healthcare practitioner. The description also states that TaperDex is not equivalent to any dexamethasone 1.5 mg and does not have a generic substitute.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.